• Advanced Cell Technology Inc. (ACT), of Marlborough, Mass., filed preliminary proxy materials with the SEC in connection with its 2013 annual stockholders meeting proposing, among other matters, to increase the authorized shares of its common stock to 3.75 billion from 2.75 billion.